Evaluation of Passive Immunity Induced by Immunisation Using Two Inactivated gE-deleted Marker Vaccines against Infectious Bovine Rhinotracheitis (IBR) in Calves

Different types of vaccines against Infectious Bovine Rhinotracheitis (IBR) are commercially available. Among these, inactivated glycoprotein E (gE)-deleted marker vaccines are commonly used, but their ability to induce passive immunity is poorly known. Here, we evaluated the passive immunity transferred from dams immunised with commercial inactivated gE-deleted marker vaccines to calves. We vaccinated 12 pregnant cattle devoid of neutralising antibodies against Bovine alphaherpesvirus 1 (BoHV-1) and divided them into two groups with 6 animals each. Both groups were injected with a different inactivated gE-deleted marker vaccine administrated via intranasal or intramuscular routes. An additional 6 pregnant cattle served as the unvaccinated control group. After calving, the number of animals in each group was increased by the newborn calves. In the dams, the humoral immune response was evaluated before calving and, subsequently, at different times until post-calving day 180 (PCD180). In addition, the antibodies in colostrum, milk, and in serum samples from newborn calves were evaluated at different times until PCD180. The results indicated that inactivated glycoprotein E (gE)-deleted marker vaccines are safe and produce a good humoral immune response in pregnant cattle until calving and PCD180. Moreover, results showed that, in calf serum, passive immunity persists until PCD180.

[1]  Strains , 2020, Encyclopedia of Continuum Mechanics.

[2]  C. Righi,et al.  Antibody Responses to Bovine Alphaherpesvirus 1 (BoHV-1) in Passively Immunized Calves , 2019, Viruses.

[3]  S. Babiuk,et al.  Colostrum transfer of neutralizing antibodies against lumpy skin disease virus from vaccinated cows to their calves , 2018, Transboundary and emerging diseases.

[4]  R. Guarcini,et al.  National surveillance plan for infectious bovine rhinotracheitis (IBR) in autochthonous Italian cattle breeds: Results of first year of activity. , 2018, Veterinary microbiology.

[5]  G. Perry,et al.  Bovine herpesvirus 1 modified live virus vaccines for cattle reproduction: Balancing protection with undesired effects. , 2017, Veterinary microbiology.

[6]  B. Newcomer,et al.  Prevention of abortion in cattle following vaccination against bovine herpesvirus 1: A meta-analysis. , 2017, Preventive veterinary medicine.

[7]  L. Bertolotti,et al.  Surveillance of Infectious Bovine Rhinotracheitis in marker-vaccinated dairy herds: Application of a recombinant gE ELISA on bulk milk samples. , 2017, Veterinary immunology and immunopathology.

[8]  C. Hedegaard,et al.  Passive immunisation, an old idea revisited: Basic principles and application to modern animal production systems , 2016, Veterinary Immunology and Immunopathology.

[9]  Billy I. Smith,et al.  Anti-bovine herpesvirus and anti-bovine viral diarrhea virus antibody responses in pregnant Holstein dairy cattle following administration of a multivalent killed virus vaccine. , 2015, American journal of veterinary research.

[10]  R. Eberle,et al.  Bovine herpesvirus-1: evaluation of genetic diversity of subtypes derived from field strains of varied clinical syndromes and their relationship to vaccine strains. , 2015, Vaccine.

[11]  A. Viltrop,et al.  Epidemiology and control of bovine herpesvirus 1 infection in Europe. , 2014, Veterinary journal.

[12]  D. Bednarek,et al.  Stimulation and analysis of the immune response in calves from vaccinated pregnant cows , 2014, Research in Veterinary Science.

[13]  D. Anziliero,et al.  A recombinant bovine herpesvirus 5 defective in thymidine kinase and glycoprotein E is immunogenic for calves and confers protection upon homologous challenge and BoHV-1 challenge. , 2011, Veterinary microbiology.

[14]  A. Amici,et al.  Evaluation of safety and efficacy of DNA vaccines against bovine herpesvirus-1 (BoHV-1) in calves. , 2011, Comparative immunology, microbiology and infectious diseases.

[15]  M. Kumar,et al.  Bovine herpes virus infections in cattle , 2009, Animal Health Research Reviews.

[16]  J. Cervenak,et al.  The neonatal Fc receptor plays a crucial role in the metabolism of IgG in livestock animals. , 2009, Veterinary immunology and immunopathology.

[17]  V. Gerdts,et al.  Humoral and cellular factors of maternal immunity in swine. , 2009, Developmental and comparative immunology.

[18]  J. G. Kirkpatrick,et al.  Effect of age at the time of vaccination on antibody titers and feedlot performance in beef calves. , 2008, Journal of the American Veterinary Medical Association.

[19]  S. V. D. L. D. Hurk.  Cell-mediated immune responses induced by BHV-1: rational vaccine design. , 2007 .

[20]  S. van Drunen Littel-van den Hurk.  Cell-mediated immune responses induced by BHV-1: rational vaccine design , 2007, Expert review of vaccines.

[21]  S. Hübner,et al.  Partial Protection Induced by a BHV‐1 Recombinant Vaccine against Challenge with BHV‐5 , 2004, Annals of the New York Academy of Sciences.

[22]  M. Payton,et al.  Maternally derived humoral immunity to bovine viral diarrhea virus (BVDV) 1a, BVDV1b, BVDV2, bovine herpesvirus-1, parainfluenza-3 virus bovine respiratory syncytial virus, Mannheimia haemolytica and Pasteurella multocida in beef calves, antibody decline by half-life studies and effect on response t , 2004, Vaccine.

[23]  E. Vanopdenbosch,et al.  Enhancement of the immune response and virological protection of calves against bovine herpesvirus type 1 with an inactivated gE-deleted vaccine , 2003, Veterinary Record.

[24]  L. Turin,et al.  BHV-1 infection in cattle: an update. , 2003, CABI Reviews.

[25]  T. Terhune,et al.  Safety of a modified-live combination vaccine against respiratory and reproductive diseases in pregnant cows. , 2003, Veterinary therapeutics : research in applied veterinary medicine.

[26]  W. Johnson,et al.  Predicted ages of dairy calves when colostrum-derived bovine viral diarrhea virus antibodies would no longer offer protection against disease or interfere with vaccination. , 2002, Journal of the American Veterinary Medical Association.

[27]  A. Rotola,et al.  A study on latency in calves by five vaccines against bovine herpesvirus-1 infection. , 2002, Comparative immunology, microbiology and infectious diseases.

[28]  A. Rotola,et al.  Vaccination of calves against bovine herpesvirus-1: assessment of the protective value of eight vaccines. , 2002, Comparative immunology, microbiology and infectious diseases.

[29]  J. Quigley.  Passive immunity in newborn calves. , 2002 .

[30]  M. Francis,et al.  Serological, colostral and milk responses of cows vaccinated with a single dose of a combined vaccine against rotavirus, coronavirus and Escherichia coli F5 (K99) , 2001, Veterinary Record.

[31]  M. Lemaire,et al.  Antibody response to glycoprotein E after bovine herpesvirus type 1 infection in passively immunised, glycoprotein E-negative calves , 1999, Veterinary Record.

[32]  J. Bosch,et al.  Inactivated bovine herpesvirus 1 marker vaccines are more efficacious in reducing virus excretion after reactivation than a live marker vaccine. , 1997, Vaccine.

[33]  J. Stegeman,et al.  The use of marker vaccines in eradication of herpesviruses. , 1996, Journal of biotechnology.

[34]  L. Babiuk,et al.  Protection of newborn calves against fatal multisystemic infectious bovine rhinotracheitis by feeding colostrum from vaccinated cows. , 1987, Canadian journal of veterinary research = Revue canadienne de recherche veterinaire.

[35]  D. Johnson,et al.  Effect of maternal antibody upon vaccination with infectious bovine rhinotracheitis and bovine virus diarrhea vaccines. , 1985, Canadian journal of comparative medicine : Revue canadienne de medecine comparee.

[36]  H. Dupont,et al.  Cytotoxicity of human peripheral blood and colostral leukocytes against Shigella species , 1984, Infection and immunity.

[37]  Z. Pospíšil,et al.  Demonstration of Colostral Antibodies in the Nasal Secretions of Calves and Their Protective Effect against Infection , 1983 .

[38]  Kucera Cj,et al.  Evaluation of the safety and efficacy of an intranasal vaccine containing a temperature-sensitive strain of infectious bovine rhinotracheitis virus. , 1978 .

[39]  R. G. White,et al.  Evaluation of the safety and efficacy of an intranasal vaccine containing a temperature-sensitive strain of infectious bovine rhinotracheitis virus. , 1978, American journal of veterinary research.